Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

207 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Inhaled corticosteroid reduction and elimination in patients with persistent asthma receiving salmeterol: a randomized controlled trial.
Lemanske RF Jr, Sorkness CA, Mauger EA, Lazarus SC, Boushey HA, Fahy JV, Drazen JM, Chinchilli VM, Craig T, Fish JE, Ford JG, Israel E, Kraft M, Martin RJ, Nachman SA, Peters SP, Spahn JD, Szefler SJ; Asthma Clinical Research Network for the National Heart, Lung, and Blood Institute. Lemanske RF Jr, et al. Among authors: boushey ha. JAMA. 2001 May 23-30;285(20):2594-603. doi: 10.1001/jama.285.20.2594. JAMA. 2001. PMID: 11368733 Clinical Trial.
Long-acting beta2-agonist monotherapy vs continued therapy with inhaled corticosteroids in patients with persistent asthma: a randomized controlled trial.
Lazarus SC, Boushey HA, Fahy JV, Chinchilli VM, Lemanske RF Jr, Sorkness CA, Kraft M, Fish JE, Peters SP, Craig T, Drazen JM, Ford JG, Israel E, Martin RJ, Mauger EA, Nachman SA, Spahn JD, Szefler SJ; Asthma Clinical Research Network for the National Heart, Lung, and Blood Institute. Lazarus SC, et al. Among authors: boushey ha. JAMA. 2001 May 23-30;285(20):2583-93. doi: 10.1001/jama.285.20.2583. JAMA. 2001. PMID: 11368732 Clinical Trial.
An evaluation of colchicine as an alternative to inhaled corticosteriods in moderate asthma. National Heart, Lung, and Blood Institute's Asthma Clinical Research Network.
Fish JE, Peters SP, Chambers CV, McGeady SJ, Epstein KR, Boushey HA, Cherniack RM, Chinchilli VM, Drazen JM, Fahy JV, Hurd SS, Israel E, Lazarus SC, Lemanske RF, Martin RJ, Mauger EA, Sorkness C, Szefler SJ. Fish JE, et al. Among authors: boushey ha. Am J Respir Crit Care Med. 1997 Oct;156(4 Pt 1):1165-71. doi: 10.1164/ajrccm.156.4.9703012. Am J Respir Crit Care Med. 1997. PMID: 9351617 Clinical Trial.
The effect of polymorphisms of the beta(2)-adrenergic receptor on the response to regular use of albuterol in asthma.
Israel E, Drazen JM, Liggett SB, Boushey HA, Cherniack RM, Chinchilli VM, Cooper DM, Fahy JV, Fish JE, Ford JG, Kraft M, Kunselman S, Lazarus SC, Lemanske RF, Martin RJ, McLean DE, Peters SP, Silverman EK, Sorkness CA, Szefler SJ, Weiss ST, Yandava CN. Israel E, et al. Among authors: boushey ha. Am J Respir Crit Care Med. 2000 Jul;162(1):75-80. doi: 10.1164/ajrccm.162.1.9907092. Am J Respir Crit Care Med. 2000. PMID: 10903223 Clinical Trial.
The utility of peak flow, symptom scores, and beta-agonist use as outcome measures in asthma clinical research.
Leone FT, Mauger EA, Peters SP, Chinchilli VM, Fish JE, Boushey HA, Cherniack RM, Drazen JM, Fahy JV, Ford J, Israel E, Lazarus SC, Lemanske RF, Martin RJ, McGeady SJ, Sorkness C, Szefler SJ; Asthma Clinical Research Network of the National Heart, Lung, and Blood Institute. Leone FT, et al. Among authors: boushey ha. Chest. 2001 Apr;119(4):1027-33. doi: 10.1378/chest.119.4.1027. Chest. 2001. PMID: 11296165
Effect of polymorphism of the beta(2)-adrenergic receptor on response to regular use of albuterol in asthma.
Israel E, Drazen JM, Liggett SB, Boushey HA, Cherniack RM, Chinchilli VM, Cooper DM, Fahy JV, Fish JE, Ford JG, Kraft M, Kunselman S, Lazarus SC, Lemanske RF Jr, Martin RJ, McLean DE, Peters SP, Silverman EK, Sorkness CA, Szefler SJ, Weiss ST, Yandava CN; National Heart, Lung, and Blood Institute's Asthma Clinical Research Network. Israel E, et al. Among authors: boushey ha. Int Arch Allergy Immunol. 2001 Jan-Mar;124(1-3):183-6. doi: 10.1159/000053705. Int Arch Allergy Immunol. 2001. PMID: 11306963
Body mass index and phenotype in subjects with mild-to-moderate persistent asthma.
Sutherland ER, Lehman EB, Teodorescu M, Wechsler ME; National Heart, Lung, and Blood Institute's Asthma Clinical Research Network. Sutherland ER, et al. J Allergy Clin Immunol. 2009 Jun;123(6):1328-34.e1. doi: 10.1016/j.jaci.2009.04.005. J Allergy Clin Immunol. 2009. PMID: 19501235 Free PMC article.
207 results